Search Results

Tegafur

• Source: Meyler's Side Effects of Drugs.

Record details

Case Report: A Case of Locally Advanced Pancreatic Cancer Which Achieved Progression Free for Over 12 Months by Subsequent Therapy with Anlotinib Hydrochloride Plus Tegafur-Gimeracil-Oteracil Potassium (TS-1).

• Authors : Dongcheng Luo; Sina Liao; Qian Li

Subjects: PANCREATIC cancer; CANCER patients; CANCER cell proliferation

• Source: Frontiers in Oncology; 7/1/2022, Vol. 12, p1-10, 10p

Record details

Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer.

• Authors : Pericay Pijaume, Carles; Escudero Emperador, Pilar; Bastús Piulats, Román

• Source: Clinical & Translational Oncology; Jan2011, Vol. 13 Issue 1, p61-66, 6p

Record details

A Phase I Study of Oral Uracil-Tegafur Prior to Weekly Intravenous Gemcitabine in Patients with Advanced Pancreatic Cancer.

• Authors : Tanno, Satoshi; Nakano, Yasuhiro; Osanai, Manabu

Subjects: PANCREATIC cancer; ANTINEOPLASTIC agents; CANCER patients

• Source: Chemotherapy (0009-3157); 2006, Vol. 52 Issue 2, p98-102, 5p, 4 Charts

Record details

A Randomized Phase II Trial of Adjuvant Chemotherapy With Uracil/Tegafur and Gemcitabine Versus Gemcitabine Alone in Patients With Resected Pancreatic Cancer.

• Authors : Yoshitomi, Hideyuki; Togawa, Akira; Kimura, Fumio

Subjects: DRUG therapy; CANCER patients; PANCREATIC cancer

• Source: Cancer (0008543X); Nov2008, Vol. 113 Issue 9, p2448-2456, 9p

Record details

Phase II Study of Gemcitabine Combined with Uracil-Tegafur in Metastatic Pancreatic Cancer.

• Authors : Jeeyun Lee; Joon Oh Park; Won Seog Kim

Subjects: PANCREATIC tumors; PANCREAS; ADENOCARCINOMA

• Source: Oncology; 2004, Vol. 66 Issue 1, p32-37, 6p, 5 Charts

Record details

Phase II Study of Uracil-Tegafur in Patients with Metastatic Pancreatic Cancer.

• Authors : Ueno, Hideki; Okada, Shuichi; Okusaka, Takuji

Subjects: URACIL; HETEROCYCLIC compounds; PYRIMIDINES

• Source: Oncology; 2002, Vol. 62 Issue 3, p223-227, 5p

Record details

Primary Pancreatic Hepatoid Carcinoma: A Case Report and Literature Review.

• Authors : Tyng-Wei Yang; Hsiang-Fong Kao

Subjects: PANCREATIC cancer treatment; CANCER relapse; PATHOLOGY

• Source: Journal of Cancer Research & Practice; Jul-Sep2023, Vol. 10 Issue 3, p113-117, 5p

Record details

Impact of S‐1 adjuvant chemotherapy longer than 6 months on survival in patients with resected pancreatic cancer: a nationwide survey by the Japan Pancreas Society based on real‐world data.

• Authors : Tomimaru, Yoshito; Eguchi, Hidetoshi; Inoue, Yosuke

Subjects: ADJUVANT chemotherapy; PANCREATIC cancer; OVERALL survival

• Source: Cancer (0008543X); Mar2023, Vol. 129 Issue 5, p728-739, 12p

Record details

A real-world study of anlotinib combined with GS regimen as first-line treatment for advanced pancreatic cancer.

• Authors : Gouling Zhan; Jianbing Hu; Shijian Da

Subjects: PANCREATIC cancer; PROGRESSION-free survival; OVERALL survival

• Source: Frontiers in Endocrinology; 1/20/2023, Vol. 14, p1-8, 8p

Record details